Sevelamer Carbonate Tablet, Film Coated
Product Images NDC 0615-8239
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Sevelamer Carbonate (NDC 0615-8239). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Ncs Healthcare Of Ky, Llc Dba Vangard Labs, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 3 (Sevelmer Carbonate Tabs 800mg 2)
The text provides a figure showing the percentage of patients who achieved a decrease in serum phosphorus levels from baseline (in mg/dL) with the use of Sevelamer Hydrochloride. The X-axis represents the reduction in phosphorus levels, and the Y-axis represents the percentage of patients who achieved that reduction. The figure also shows categories for indicating whether the change from baseline was worsened, improved, increased, or reduced.*
Figure 4 (Sevelmer Carbonate Tabs 800mg 3)
Principal Display Panel (Sevelamer Carbonate Tabs 800mg)
This is a medication label for Sevelamer Carbonate 800mg tablets manufactured by Aurobindo Pharma. The tablets are used to treat high phosphate levels in the blood of people with chronic kidney disease who are on dialysis. The tablets should be stored at a temperature of 20°- 25°C (68°-77°F). The medication should be protected from moisture and dispensed in a tightly closed container. The lot numbers and expiration dates for the tablets are listed on the label. Dosage instructions should be obtained from the package insert or label.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.